MENU
VIRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Viracta Therapeutics (VIRX) Ownership - Who owns Viracta Therapeutics?
Industry: @Biotechnology
Profile
Industry
Biotechnology
Address
2533 South Coast Highway 101
Phone
+1 858 400-8470
Employees
40
Web
https://www.viracta.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.57M
P/E Ratio
N/A
Total Cash
21.13M
Projected Growth
N/A
Total Debt
16.91M
Revenue
N/A
Risk (Beta)
0.45
Dividend Yield
N/A
Total Cash/Share
0.53
Total Debt/Equity
61.96
Revenue/Share
null USD as % of share price
Fundamentals
VIRX
Capitalization
8.57M
P/E Ratio
N/A
Risk (Beta)
0.45
Dividend Yield
N/A
Total Cash
21.1M
Total Cash/Share
0.53
Total Debt
16.9M
Total Debt/Equity
61.96
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-6.62M
P/B Ratio
2.43
Cash Flow
N/A
Earnings
-1.1
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
4K
Current Ratio
0.76
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-39.67M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-97.94
Shares Held By Institutions
2.83M
Shares Outstanding - Current
39.7M
Total Liabilities
28.6M
Total Volume MTD
N/A
Value
-1
Gain YTD
-62.175
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of oncology therapeutics for treatment of solid and hematologic cancers
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
2533 South Coast Highway 101
Phone
+1 858 400-8470
Employees
40
Web
https://www.viracta.com